Segmentation by types classifies the market according to the analytical technologies employed for peptide characterization. Mass spectrometry (MS), encompassing MALDI‑TOF, ESI‑MS, and LC‑MS/MS, dominates due to its unmatched sensitivity and sequence‑level resolution, supporting both discovery and quality‑control workflows. High‑performance liquid chromatography (HPLC), particularly reversed‑phase and ion‑exchange variants, remains essential for purity assessment and quantitation, offering robust, reproducible separations across diverse peptide chemistries. Capillary electrophoresis (CE) provides high efficiency for charge‑based separations, catering to rapid screening of peptide mixtures with minimal sample consumption. Nuclear magnetic resonance (NMR), though less prevalent, delivers definitive three‑dimensional structural insight, valuable for lead optimization and conformational studies. Immunoassays, such as ELISA and multiplexed platforms, serve niche applications where high‑throughput, antibody‑based detection of specific peptide epitopes is required. The relative adoption of each type is dictated by analytical goals—structural elucidation, quantitative purity, or biomarker detection—thereby influencing capital investment patterns and service revenue streams within the overall market.